Dr. Lal PathLabs Ltd. reported its financial results for the quarter ended June 30, 2025 (Q1 FY26), showing a healthy improvement in both topline and bottomline.
Key Highlights:
-
Revenue from Operations: ₹669.8 crore, up from ₹601.9 crore in Q1 FY25
-
Total Income: ₹697.9 crore vs ₹622.5 crore YoY
-
Net Profit: ₹134 crore, up 24.3% year-on-year from ₹107.8 crore in Q1 FY25
-
Profit Before Tax: ₹181.1 crore vs ₹149.9 crore YoY
The company’s operational strength was reflected in the rise in both employee benefits and collection channel fees, indicating expanding diagnostic activity. Profitability also improved despite a modest increase in total expenses.
With stable performance and a consistent upward trend in earnings, Dr. Lal PathLabs continues to strengthen its leadership in the diagnostics sector.
